Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Clinical trial NCT06475742 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06475742
- Sponsor
- Viatris Innovation GmbH
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2028-05-01
- Enrollment
- 680
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.